ARVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
ARVINAS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$7.26+0.29 (+4.16%)
Close on Oct 19, 2026
- Market cap
- $476.98M
- P/E (TTM)
- 45.4
- Dividend yield
- –
Arvinas statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Arvinas | Industry median |
|---|---|---|
| Market Cap | $474.70M | $166.30M |
| Enterprise Value | -$92.70M | $88.19M |
| PE Ratio | 45.38 | 20.44 |
| PS Ratio | 1.50 | 3.65 |
| PB Ratio | 0.84 | 2.03 |
| P/TBV Ratio | 0.84 | 2.29 |
Enterprise value
| Measure | Arvinas | Industry median |
|---|---|---|
| EV / Sales | -0.29 | 2.51 |
Income (trailing twelve months)
| Measure | Arvinas | Industry median |
|---|---|---|
| Revenue | $316.70M | $58.34M |
| Operating Income | -$18.10M | -$21.40M |
| Pretax Income | $10.10M | -$14.34M |
| Net Income | $9.30M | -$22.46M |
| EBITDA | -$15.20M | -$16.91M |
| EPS (Diluted) | $0.16 | -$0.83 |
Margins
| Measure | Arvinas | Industry median |
|---|---|---|
| Operating Margin | -5.72% | -44.0% |
| Pretax Margin | 3.19% | -13.3% |
| Profit Margin | 2.94% | -40.2% |
| EBITDA Margin | -4.80% | -30.2% |
| FCF Margin | -65.9% | -9.27% |
Returns
| Measure | Arvinas | Industry median |
|---|---|---|
| Return on Equity (ROE) | 1.59% | -53.2% |
| Return on Assets (ROA) | 1.17% | -40.9% |
| Return on Capital Employed (ROCE) | -3.05% | -38.1% |
Growth
| Measure | Arvinas | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -15.0% | 5.96% |
| Revenue Growth (3Y CAGR) | 26.0% | 2.25% |
| Revenue Growth (5Y CAGR) | 58.9% | 6.48% |
Balance sheet
| Measure | Arvinas | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $567.90M | $61.43M |
| Total Debt | $500.00K | $118.52M |
| Net Cash (Debt) | $567.40M | $15.35M |
| Net Cash Per Share | $8.68 | $0.66 |
| Equity (Book Value) | $562.20M | $49.09M |
| Book Value Per Share | $8.60 | $1.37 |
| Tangible Book Value | $562.20M | $23.52M |
| Working Capital | $569.70M | $76.81M |
Financial position
| Measure | Arvinas | Industry median |
|---|---|---|
| Current Ratio | 7.91 | 3.34 |
| Quick Ratio | 7.49 | 2.44 |
| Debt / Equity | 0.00 | 0.52 |
Cash flow (trailing twelve months)
| Measure | Arvinas | Industry median |
|---|---|---|
| Operating Cash Flow | -$207.00M | -$12.35M |
| Capital Expenditures | -$1.80M | -$1.08M |
| Free Cash Flow | -$208.80M | -$20.22M |
| FCF Per Share | -$3.19 | -$0.42 |
Efficiency
| Measure | Arvinas | Industry median |
|---|---|---|
| Asset Turnover | 0.40 | 0.39 |
| Revenue Per Employee | $1.29M | $404.87K |
| Profits Per Employee | $37.80K | -$703.34K |
| Employee Count | 246 | 74 |
Dividends and yields
| Measure | Arvinas | Industry median |
|---|---|---|
| Earnings Yield | 1.96% | -23.3% |
| FCF Yield | -44.0% | -8.72% |
Shares
| Measure | Arvinas | Industry median |
|---|---|---|
| Shares Outstanding | 65,386,200 | 58,127,000 |
| Shares Change (YoY) | -7.56% | 10.9% |
| Shares Change (QoQ) | 1.24% | 0.54% |
| Float | 60,300,500 | 49,136,700 |
| Shares Held by Insiders | 7.78% | 11.6% |
| Shares Held by Institutions | 86.0% | 59.4% |
Taxes
| Measure | Arvinas | Industry median |
|---|---|---|
| Income Tax | $800.00K | $79.87K |
| Effective Tax Rate | 7.92% | 20.6% |
Scores
| Measure | Arvinas | Industry median |
|---|---|---|
| Graham Number | $5.56 | $18.73 |
| Graham Upside | -23.4% | -45.1% |
| Altman Z-Score | 0.80 | -0.22 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Arvinas's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.